Literature DB >> 2940963

Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets.

L J Goodman, R L Kaplan, R M Petrak, R M Fliegelman, D Taff, F Walton, J L Penner, G M Trenholme.   

Abstract

Ciprofloxacin was compared with erythromycin for the eradication of Campylobacter species that were chronically excreted in the stools of marmosets (Saguinus labiatus labiatus, Saguinus fuscicollis nigrifrons, and Saguinus fuscicollis illigeri). Stool cultures were negative within 48 h of the beginning of treatment with either agent. Within 10 days after the end of therapy, however, Campylobacter species were again isolated from the stools of six animals that had received erythromycin. During an 8-week follow-up period, no animal that had received ciprofloxacin relapsed. High levels of ciprofloxacin in the stool (mean, 49.2 micrograms/g) possibly contributed to the efficacy of this agent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940963      PMCID: PMC176374          DOI: 10.1128/AAC.29.2.185

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Rapid hippurate hydrolysis method for presumptive identification of group B streptococci.

Authors:  M N Hwang; G M Ederer
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

2.  Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration.

Authors:  R L Nichols; R E Condon; A R DiSanto
Journal:  Arch Surg       Date:  1977-12

3.  Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors:  B Crump; R Wise; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

4.  Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors:  L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

5.  Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man.

Authors:  C L Hartley; H M Clements; K B Linton
Journal:  J Med Microbiol       Date:  1978-05       Impact factor: 2.472

6.  Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.

Authors:  R M Fliegelman; R M Petrak; L J Goodman; J Segreti; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

7.  Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes.

Authors:  J A Kiehlbauch; R A Albach; L L Baum; K P Chang
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

  7 in total
  3 in total

Review 1.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 2.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 3.  Clinical Management of Gastrointestinal Disease in the Common Marmoset (Callithrix jacchus).

Authors:  Casey Fitz; Anna Goodroe; Lauren Wierenga; Andres Mejia; Heather Simmons
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.